Understanding Cardiac Arrest Treatment Options
Limited Options for Emergency Workers
Emergency workers face significant challenges when responding to individuals experiencing cardiac arrest. While cardiopulmonary resuscitation (CPR) and immediate defibrillation have been shown to be effective, many alternative treatments lack demonstrated safety and efficacy.
Conflicting Evidence Surrounding Epinephrine
Epinephrine, commonly known as adrenaline, is one medication that presents conflicting evidence regarding its safety and effectiveness in cardiac arrest situations. Naturally occurring in the body, epinephrine can elevate blood pressure and enhance blood flow to the heart. Administering larger doses during a cardiac arrest may potentially help restart the heart.
The Debate on Epinephrine’s Role
Given the potential life-saving properties of epinephrine, why is there controversy surrounding its use? Research indicates that patients who receive epinephrine during cardiac arrest may experience significant brain damage. In light of this, the International Liaison Committee on Resuscitation has advocated for clinical trials to assess the safety and effectiveness of epinephrine in such emergencies.
Overview of the Clinical Trial
A recent clinical trial conducted in the United Kingdom and published in the New England Journal of Medicine aimed to clarify the role of epinephrine in out-of-hospital cardiac arrests. The study focused exclusively on patients who suffered cardiac arrest outside a hospital setting. Paramedics were provided with a research package that included either a syringe of epinephrine or a saline solution as a placebo. The paramedics were blinded to which syringe they administered, minimizing bias in the results.
Over the three-year study period, 8,014 cardiac arrest patients were included. Due to the urgent nature of cardiac arrest, prior consent from patients was not feasible.
Findings and Implications
The results indicated that patients administered epinephrine had a higher likelihood of survival 30 days post-cardiac arrest compared to those who received the placebo. However, this increase in survival was coupled with a higher incidence of brain damage among those treated with epinephrine.
This outcome raises an ethical dilemma: is it preferable to use epinephrine and achieve survival, even at the potential cost of brain function? Previous research suggests that many patients and the public prioritize survival with intact brain function over mere survival.
The researchers noted that the benefits of epinephrine in improving cardiac arrest outcomes are significantly overshadowed by the advantages provided by CPR and defibrillation. Nevertheless, they refrained from making definitive recommendations on the use of epinephrine, leaving the decision to policymakers.
Reference
Perkins G, Ji C, Deakin C, et al. A Randomized Trial of Epinephrine in Out-of-Hospital Cardiac Arrest. New Engl J Med. 2018. doi:10.1056/NEJMoa1806842.